What Is Blue Scorpion Venom? Does It Have a Role in Cancer Treatment?
In this article
What is blue scorpion venom? Does it have a role in cancer treatment?
Cuban blue scorpion venom products (Escozul, Escozine and Vidatox) have been marketed online and on social media for years as “natural cancer treatments.” Patients and relatives may pay high prices in hope. Yet as of September 2026, not a single controlled clinical trial shows these products treat cancer or prolong life in humans. Meanwhile, certain purified molecules derived from scorpion venom show promise in genuine scientific research. This article separates these two stories and explains what is known and unknown using current sources.
- What is it? Venom obtained from Cuba’s blue scorpion (Rhopalurus junceus). LABIOFAM produces it in Cuba as diluted venom (Escozul) and a homeopathic product (Vidatox 30 CH).
- Evidence: Positive findings come only from cell and animal experiments. There are no controlled human trials; Memorial Sloan Kettering Cancer Center (MSKCC) states its cancer-treatment effect is unproven and it has not been evaluated by the United States Food and Drug Administration (FDA).
- Vidatox is a contradiction: “30 CH” means homeopathic dilution; at this dilution, practically no venom molecule remains.
- Potential harm: In a laboratory study published in 2017, Vidatox’s effect on liver cancer cells was that their proliferation and ability to spread increased.
- Where is the real science? From another scorpion species, chlorotoxin is being studied as a dye marking brain tumors during surgery and as CAR-T cell therapy; no product is yet approved.
- Added that Vidatox is homeopathic and explained “30 CH” dilution.
- Added the 2017 laboratory study showing Vidatox increased tumor growth in liver cancer cells.
- Corrected chlorotoxin’s origin: it comes from another scorpion species, not the blue scorpion; added the 2025-2026 status of chlorotoxin dye (tozuleristide) and chlorotoxin CAR-T therapy.
- Removed outdated prices; added an evidence ladder and diagrams showing two scorpions’ different stories.
What is blue scorpion venom?
Scorpions use venom through the sting at the tip of their tails to paralyze prey and defend themselves. Composition varies by species; only a small proportion of thousands of species have venom life-threatening to humans. Scorpions have been used in many traditional medical systems, particularly Traditional Chinese Medicine, for pain, spasms and seizures.
“Blue scorpion” is the name for the Cuban species Rhopalurus junceus (currently classified as Heteroctenus junceus). In Cuba, a diluted solution of its venom has traditionally been used as an anti-inflammatory known as escozul (“escorpión azul,” meaning blue scorpion). Products were developed by Cuba’s state-owned LABIOFAM. According to a 2011 report, research lasted 15 years; only about 0,02 mL of venom can be obtained from each scorpion.
Escozul, Escozine and Vidatox: What is the difference?
- Escozul / Escozine: Scorpion venom diluted with water. According to MSKCC, Cuba rejected Escozul use in 2009 because of insufficient clinical data.
- Vidatox 30 CH: The same venom, homeopathically diluted to an extremely high degree. It is produced in Cuba as a homeopathic medicine. A Cuban news site reported in 2017 that its purpose there is “improving cancer patients’ quality of life by reducing disease-related symptoms.” Even in Cuba, it is described as a symptom-relief product, not a cancer-treating medicine.
There is an important contradiction. In homeopathy, “C” means a 100-fold dilution; “30 C” means repeating this 30 times, giving a 1060 -fold dilution. Since a mole contains approximately 6 × 1023 molecules, in such a diluted solution practically not even one venom molecule remains. Marketing Vidatox through “scorpion venom’s effects on cancer cells” is therefore internally inconsistent. We discuss homeopathy’s place in cancer treatment in what is homeopathy in detail.
Figure 1 · What does “30 CH” mean?
Homeopathic dilution is sufficient to eliminate the venom entirely.
What claims are used in marketing?
Products are sold with claims of treating cancer, shrinking tumors, relieving pain, strengthening immunity and preventing chemotherapy side effects. According to one scientist, because manufacturers cannot officially promote them as cancer medicines, marketing emphasizes analgesic and anti-inflammatory effects. The table compares claims with evidence:
| Claim | Basis | Human evidence |
|---|---|---|
| Treats cancer, shrinks tumors | Cell and animal experiments | none |
| Relieves pain | Animal experiments; uncontrolled observations in Cuba | none No controlled study published |
| Strengthens immunity | Laboratory findings | none |
| Natural, no side effects | Marketing language | unknown Side effects and drug interactions not studied |
| Used to treat cancer in Cuba | Promotional material | misleading Described in Cuba as a homeopathic symptom-relief product |
Common misconceptions about Cuba’s health system and cancer data are discussed in the reality of cancer in Cuba through its own official data in our article.
What do scientific studies say?
The scientific literature contains numerous laboratory studies of scorpion venoms’ effects on cancer cells. They report that different species’ venoms slow proliferation and trigger programmed cell death (apoptosis) in breast, gastric, colorectal, prostate, lung and oral cancer and leukemia cells. Most venom molecules act through cell-membrane ion channels; their role in cancer cells attracts researchers’ interest. One mouse study also reported fewer tumors after venom treatment in mice with induced skin cancer.
However, all these studies involve cell cultures or animals. MSKCC’s assessment updated in June 2023 states that scorpion venom marketed to cancer patients is not scientifically proven to treat cancer in humans; “scientific” articles published online have not been appropriately evaluated by the scientific community. Products such as Escozine and Vidatox have not undergone clinical trials or FDA evaluation. Although a Vidatox study appears in Cuba’s clinical trial registry, we could not find a controlled trial with published results. Not even one case of cancer recovery with scorpion venom is reported in peer-reviewed journals.
In 2017, Scientific Reports published a laboratory study finding that Vidatox 30 CH had no anticancer effect in liver cancer (hepatocellular carcinoma) cells but instead increased their proliferation and ability to spread . This too is a laboratory finding, not directly transferable to humans. But it demonstrates the risk of thinking “it cannot hurt, let us try it.”
A substance killing cancer cells in the laboratory does not mean it has the same effect in the human body. Only very few of thousands of substances killing cancer cells in the laboratory work in humans. Just as pouring bleach onto cancer cells and killing them does not mean drinking bleach treats cancer, laboratory effects of scorpion venom require the same skepticism. We describe a drug’s journey from laboratory to patients in cancer drug discovery and approval and how laboratory findings can be presented misleadingly in how apparently solid research misleads the public .
Figure 2 · Scorpion-derived products on the evidence ladder
A treatment must be supported by controlled human studies to be considered reliable.
Could a genuine cancer medicine come from a scorpion?
Yes, this is possible and under investigation, but should not be confused with blue scorpion venom products. Our earlier version described chlorotoxin as a component of blue scorpion venom. In fact, chlorotoxin is a small protein derived from another species living in the Middle East and North Africa (Leiurus quinquestriatus, the yellow scorpion). Chlorotoxin can bind selectively to nervous-system tumor cells such as glioma cells. Researchers exploit this not by using natural venom but a purified, laboratory-produced molecule :
Figure 3 · Two scorpions, two different stories
Marketed natural venom and a purified, tested molecule are not the same.
We discuss current brain-tumor approaches in the latest developments in glioblastoma treatment and the development of CAR-T in the story of CAR-T therapy .
Is scorpion venom safe?
Because diluted scorpion venom products have not undergone controlled human trials, their side effects, effects on cancer treatment and drug interactions are unknown. Their toxic effects on the nervous system (neurotoxicity) are well known. MSKCC warns that the venom contains phospholipase A2, potentially affecting clotting and interacting with blood thinners; it also reports the death of an 86-year-old lung cancer patient using this product.
Perhaps the greatest risk is indirect: delaying or abandoning proven treatment, or spending time and money on these products. We discuss why alternative products can be dangerous in this article .
- Blue scorpion venom products are not licensed medicines in Türkiye; they are usually sold online as “treatment from Cuba.” We could not find a product-specific warning from the Ministry of Health or Turkish Medicines and Medical Devices Agency (TİTCK).
- Our earlier version reported a 2016 announcement from the Republic of Türkiye Embassy in Havana stating that even Cuban oncologists did not use Vidatox for treatment.
- Oncologists in Türkiye occasionally warn against these products through the press, for example in December 2021.
- If considering or currently using them, always tell your oncologist; they may interact with your treatment.
Frequently asked questions
- Does blue scorpion venom treat cancer?
- No human study shows this. Positive findings come only from cell and animal experiments and have not been confirmed in humans.
- Can I use it as “support” alongside chemotherapy?
- It is not recommended. Interactions with cancer drugs have not been studied; effects on clotting and increased tumor-cell proliferation in one laboratory study have been reported. Speak with your oncologist first if considering it. We explain the distinction between complementary and alternative treatments in this article .
- Do doctors use it in Cuba?
- Vidatox is produced in Cuba as a homeopathic product described for symptom relief; it is not approved as a cancer treatment even there.
- What is the difference between Vidatox and Escozul?
- Escozul is venom diluted with water. Vidatox is homeopathically diluted 1060 -fold; practically no venom molecules remain at this level.
- How can I access chlorotoxin treatment?
- Chlorotoxin-derived products are not yet approved and are used only in clinical trials. Patients with brain tumors can ask their oncologist about suitable trials. We explain their importance in what is a clinical trial .
- There are recovery stories online; are they lies?
- In most, the person also received standard cancer treatment, the diagnosis was not confirmed or long-term follow-up is missing. No case of cancer recovery with scorpion venom has been reported in peer-reviewed journals.
Glossary
- Homeopathy
- An alternative medicine method using extreme dilutions, with no scientifically demonstrated effectiveness.
- 30 CH / 30 C
- 30 successive 100-fold dilutions; in total 1060 -fold.
- Apoptosis
- Programmed cell death; a cell’s controlled self-destruction.
- Ion channel
- Protein structures allowing ions such as sodium, potassium and chloride to cross cell membranes.
- Chlorotoxin
- A small protein from yellow scorpion (Leiurus quinquestriatus) venom that binds selectively to certain tumor cells.
- CAR-T cell therapy
- Modifying a patient’s immune cells in the laboratory to recognize cancer cells, then returning them.
- Phase 1-3 studies
- Clinical trial stages testing a new treatment in humans sequentially for safety, signs of efficacy and comparison with standard treatment.
- Neurotoxic
- Damaging the nervous system.
DROZDOGAN Academy Commentary
Blue scorpion venom exemplifies exploitation of hope in cancer: genuine but early laboratory findings, exotic origins and powerful marketing to desperate patients.
⚡ Why it matters
Patients spend both money and their most precious resource, time, on these products. Delaying proven treatments may allow disease progression.
✅ Science’s strength
Natural venoms can genuinely yield medicines. Chlorotoxin from scorpion venom is being tested appropriately in clinical trials as a dye facilitating brain-tumor surgery and as cell therapy.
⚠️ Limitations
There are no controlled human studies of blue scorpion products. Vidatox’s homeopathic dilution makes even discussing the venom itself meaningless. One laboratory study suggests increased tumor growth.
🩺 What to do in practice
- Approach claims such as “natural,” “from Cuba” or “no side effects” skeptically .
- For a product, ask “are there controlled human studies?" question.
- Every supplement and product you use should be reported to your oncologist.
- If seeking a new treatment, clinical trials and second opinions are options to consider.
❓ Open questions
When will tozuleristide results be announced? Will chlorotoxin CAR-T demonstrate efficacy in larger trials? Can other scorpion venom molecules be used in drug development?
Our brief judgment: With current knowledge, blue scorpion venom products are not cancer treatments. A future medicine may emerge from scorpion venom, but from purified molecules tested in clinical trials, not bottles sold online. On current evidence, scorpion venom is neither a medicine nor a cure; it remains a venom.
- This is the September 2026 update of our article “What Is Blue Scorpion Venom? Does It Have a Role in Cancer Treatment?” It draws on MSKCC’s “About Herbs” assessment (June 2023), published laboratory and clinical studies, FDA and company statements, and news sources.
- Corrections to the previous version: Chlorotoxin was presented as a component of blue scorpion venom; it actually comes from another species (Leiurus quinquestriatus). Vidatox’s homeopathic dilution and its meaning were added. Some technical details of laboratory mechanisms—for example, “bcl-2 triggers cell death,” although bcl-2 actually suppresses it—were simplified because they could not be verified and might mislead. Outdated prices were removed. The laboratory study showing increased liver cancer-cell growth with Vidatox and current chlorotoxin product status were added.
- Reported from secondary sources: Cuba’s 2009 rejection of Escozul comes from MSKCC; Vidatox’s purpose in Cuba from a Cuban news site; findings of the 2017 liver cancer study from a quotation in a scientist’s blog; chlorotoxin CAR-T results from a professional news site; and production information from a news site.
- Not verified: Vidatox’s Cuban regulator (CECMED) registration date and approved indication wording; the original 2016 Turkish Embassy in Havana announcement (only in our previous version); Cuban Vidatox trial results; an official Turkish warning; tozuleristide phase 2/3 results and an approval application.
- Based on general knowledge: Scorpions’ use of venom, traditional medical use, homeopathic dilution calculations (Avogadro’s number), yellow scorpion habitat and the explanation that laboratory findings cannot be transferred directly to humans are presented as established knowledge.
- The claim–evidence table, diagrams and Academy commentary are our own. Diagrams derive from verified statements in the text and contain no new data.
- This article is not personal medical advice. Make treatment decisions together with your oncologist.
References
- Memorial Sloan Kettering Cancer Center. About Herbs: Scorpion venom. Last updated 2 June 2023.
- Scientific Reports. Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma. 2017.
- Ernst E. Vidatox: homeopathy’s answer to cancer or outright fraud? October 2019 (blog post).
- CiberCuba. News of production authorization for Vidatox 30 CH. 4 January 2017.
- Fox News. Cuba working on anti-cancer treatments using scorpion venom. 30 November 2011.
- Hockaday DC et al. Imaging glioma extent with 131I-TM-601. J Nucl Med. 2005;46(4):580-586.
- Blaze Bioscience. Press releases on FDA Fast Track for tozuleristide (April 2020) and completion of phase 2/3 enrollment (November 2022).
- FDA. Notice to Blaze Bioscience concerning ClinicalTrials.gov results reporting. January 2024.
- Barish ME et al. Chlorotoxin-directed CAR-T cells in recurrent glioblastoma: interim clinical experience on feasibility and safety. Cell Rep Med. 2025;6(8):102302.
- CancerNetwork. Chlorotoxin-based therapy shows safety, feasibility in glioblastoma. November 2025.
- Cumhuriyet. “Blue scorpion venom” warning to cancer patients. 12 December 2021.
Sources
http://havanajournal.com. (Accessed March 12, 2017)
2. Zargan J, Umar S, Sajad M, et al. Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). Toxicol In Vitro. 2011; 25:1748-1756.
3. de Roodt AR, Garcia SI, Salomon OD, et al. Epidemiological and clinical aspects of scorpionism by Tityus trivittatus in Argentina. Toxicon. 2003; 41:971-977.
4. Dabo A, Golou G, Traore MS, et al. Scorpion envenoming in the north of Mali (West Africa): epidemiological, clinical and therapeutic aspects. Toxicon. 2011; 58:154-158.
5. Zhao R, Weng CC, Feng Q, et al. Anticonvulsant activity of BmK AS, a sodium channel site 4-specific modulator. Epilepsy Behav. 2011; 20:267-276.
6. Gao B, Sherman P, Luo L, et al. Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.FASEB J. 2009; 23:1230-1245.
7. Gao B, Xu J, Rodriguez Mdel C, et al. Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus. Biochimie. 2010; 92:350-359.
8. Martin-Eauclaire MF, Abbas N, Sauze N, et al. Involvement of endogenous opioid system in scorpion toxin-induced antinociception in mice. Neurosci Lett. 2010; 482:45-50.
9. D’Suze G, Rosales A, Salazar V, et al. Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line. Toxicon. 2010; 56:1497-1505.
10. Mamelak AN, Rosenfeld S, Bucholz R, et al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol. Aug 1 2006; 24:3644-3650.
11. Xiang Y, Liang L, Wang X, et al. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Control Release. 2011; 152:402-410.
12. Veiseh M, Gabikian P, Bahrami SB, et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 2007 ;67:6882-6888.
13. Akcan M, Stroud MR, Hansen SJ, et al. Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J Med Chem. 2011; 54:782-787.
14. El-Ghlban S, Kasai T, Shigehiro T, et al. Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells. Biomed Res Int. 2014; 2014:152659.
15. Almaaytah A, Albalas Q. Scorpion venom peptides with no disulfide bridges: a review. Peptides. 2014; 51:35-45.
16. García-Gómez BI, Coronas FI, Restano-Cassulini R, Rodríguez RR, Possani LD. Biochemical and molecular characterization of the venom from the Cuban scorpion Rhopalurusjunceus. Toxicon. 2011; 58:18-27.
17. Li W, Li Y, Zhao Y, et al. Inhibition effects of scorpion venom extracts (Buthus matensii Karsch) on the growth of human breast cancer MCF-7 cells. Afr J Tradit Complement Altern Med. 2014; 11:105-110.
18. Gao F, Li H, Chen YD, et al. Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line. Leuk Lymphoma. 2009; 50:633-641.
19. Jacoby DB, Dyskin E, Yalcin M, et al. Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide. Anticancer Res. Jan 2010; 30:39-46.
20. Memorial sloan kettering cancer center, Integrative Medicine, About Herbs, Botanicals & Other Products, Scorpion Venom. Available at:
https://www.mskcc.org/cancer-care/integrative-medicine/herbs/scorpion-venom (Accessed March 12, 2017)
21. Ojeda PG, Wang CK, Craik DJ. Chlorotoxin: Structure, activity, and potential uses in cancer therapy. Biopolymers. 2016; 106:25-36.
22. Republic of Turkey Havana Embassy, Embassy Notice / 26.09.2016. Available at:
http://havana.be.mfa.gov.tr/images/localCache/12/2033baad-7303-43bb-a03d-320941e56c67.docx (Accessed March 12, 2017)
23. Al Asmari AK, Khan AQ. Investigation of in vivo potential of scorpion venom against skin tumorigenesis in mice via targeting markers associated with cancer development. Drug Des Devel Ther. 2016; 10:3387-3397.
24. Al-Asmari AK, Islam M, Al-Zahrani AM. In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines. Oncol Lett. 2016; 11:1256-1262.
25. Tong-ngam P, Roytrakul S, Sritanaudomchai H. BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis. Asian Pac J Cancer Prev. 2015; 16:2807-11.
26. Al-Asmari AK, Riyasdeen A, Abbasmanthiri R, Arshaduddin M, Al-Harthi FA. Scorpion (Androctonus bicolor) venom exhibits cytotoxicity and induces cell cycle arrest and apoptosis in breast and colorectal cancer cell lines. Indian J Pharmacol. 2016; 48:537-543.
27. Zhang YY, Wu LC, Wang ZP, Wang ZX, Jia Q, Jiang GS, Zhang WD. Anti-proliferation Effect of Polypeptide Extracted from Scorpion Venom on Human Prostate Cancer Cells in vitro. J Clin Med Res. 2009; 1:24-31.
28. Sarfo-Poku C, Eshun O, Lee KH. Medical application of scorpion venom to breast cancer: A mini-review. Toxicon. 2016; 122:109-112.
29. Zhang XY, Zhang PY. Scorpion venoms in gastric cancer. Oncol Lett. 2016; 12:3683-3686.
30. Béchohra L, Laraba-Djebari F, Hammoudi-Triki D. Cytotoxic activity of Androctonus australis hector venom and its toxic fractions on human lung cancer cell line. J Venom Anim Toxins Incl Trop Dis. 2016; 22:29.
31. Veiseh O, Kievit FM, Fang C, Mu N, Jana S, Leung MC, Mok H, Ellenbogen RG, Park JO, Zhang M. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials. 2010; 31:8032-42.
32. Satitmanwiwat S, Changsangfa C, Khanuengthong A, Promthep K et al. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells. Biomed Pharmacother. 2016; 84:1042-1050.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.